WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002026239) ANALGESIC AND GLUCOSAMINE COMPOSITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/026239    International Application No.:    PCT/US2001/029606
Publication Date: 04.04.2002 International Filing Date: 21.09.2001
Chapter 2 Demand Filed:    21.03.2002    
IPC:
A61K 31/00 (2006.01)
Applicants: TEMPLE UNIVERSITY OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION [US/US]; Broad Street and Oxford Avenue Philadelphia, PA 19122 (US)
Inventors: RAFFA, ROBERT; (US).
COWAN, Alan; (US).
TALLARIDA, Ronald; (US)
Agent: ANDERSEN, Robert, L.; Ratner & Prestia 301 One Westlakes (Berwyn) P.O. Box 980 Valley Forge, PA 19482-0980 (US)
Priority Data:
60/235,405 26.09.2000 US
Title (EN) ANALGESIC AND GLUCOSAMINE COMPOSITIONS
(FR) ANALGESIQUE ET COMPOSITIONS DE GLUCOSAMINE
Abstract: front page image
(EN)This invention relates to a composition a glucosamine material and an analgesic compound such as a nonsteroidal anti-inflammatory drug (NSAID) and/or an opiod analgesic and its use for treatment of pain in pharmaceutical or veterinary applications. When the components are administered within certain ratios, the analgesic efficacy of the composition is super-additive (synergistic) relative to the analgesic efficacy of the analgesic compound alone.
(FR)La présente invention concerne une composition comprenant une matière à base de glucosamine et un composé analgésique, tel qu'un anti-inflammatoire non stéroïdien (AINS) et/ou un analgésique opioïde, ainsi que leur utilisation pour le traitement de la douleur dans des applications pharmaceutiques ou vétérinaires. Lorsque les composants sont administrés dans certaines proportions, l'efficacité analgésique de la composition est super-additive (synergique) par rapport à l'efficacité analgésique du composé analgésique tout seul.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)